168827-86-9

Basic information

• Product Name: Carbamic acid, [(2S)-3-hydroxy-2-methylpropyl]-, 1,1-dimethylethyl ester (9CI)
• Synonyms: Carbamic acid, [(2S)-3-hydroxy-2-methylpropyl]-, 1,1-dimethylethyl ester (9CI)
• CAS NO: 168827-86-9
• Molecular Formula: C₉H₁₉NO₃
• Molecular Weight: 189.25206
• Product Categories: N-BOC
• Mol File: 168827-86-9.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Carbamic acid, [(2S)-3-hydroxy-2-methylpropyl]-, 1,1-dimethylethyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(2S)-3-hydroxy-2-methylpropyl]-, 1,1-dimethylethyl ester (9CI)(168827-86-9)
• EPA Substance Registry System: Carbamic acid, [(2S)-3-hydroxy-2-methylpropyl]-, 1,1-dimethylethyl ester (9CI)(168827-86-9)

Safety Data

• Hazardous Substances Data: 168827-86-9(Hazardous Substances Data)

Upstream product

• 168828-18-0 methyl (S)-3-(tert-butoxycarbonylamino)-2-methylpropanoate 
• 374729-55-2 (S)-tert-butyl (2-methyl-3-oxopropyl)carbamate 
• 51779-32-9 iminodicarboxylic acid di-tert-butyl ester 
• 1312771-12-2 ethyl 2-[(bis(tert-butoxycarbonyl)amino)methyl]acrylate 
• 1429320-33-1 ethyl (S)-3-(tert-butoxycarbonylamino)-2-methylpropanoate 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 374729-55-2 (S)-tert-butyl (2-methyl-3-oxopropyl)carbamate 
• 374729-51-8 tert-Butyl N-[(2R,3E)-2-methyl-3-hexen-5-ynyl]carbamate 

Relevant articles and documents

CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE

The present disclosure provides novel pladienolide compounds, pharmaceutical compositions containing such compounds, and methods for using the compounds as therapeutic agents. These compounds may be useful in the treatment of cancers, particularly cancers in which agents that target the spliceosome and mutations therein are known to be useful. Also provided herein are methods of treating cancers by administering at least one compound disclosed herein and at least one additional therapy.

Synthesis of enantiopure β2-homoalanine derivatives via rhodium catalyzed asymmetric hydrogenation

The stereoselective synthesis of chiral β2-homoalanine derivatives with 99% ee by the Rh-catalyzed enantioselective hydrogenation of prochiral 2-aminomethyl acrylates is described. The subsequent transformation to chiral 3-amino-2-methylpropanols is also demonstrated.

Rhodium-catalyzed asymmetric hydroformylation of n-allvlamides: Highly enantioselective approach to β2-amino aldehydes

(Figure Presented) You're having a lahf I The asymmetric hydroformylation (AHF) of allylic compounds, catalyzed by a rhodium-yanphos complex, is a direct and concise route to ss2-amino aldehydes, acids, and alcohols with excellent enantioselectivity (see scheme; TON =turnover number, acac = acetylacetonate).

DIPEPTIDYL PEPTIDASE-IV INHIBITING COMPOUNDS, METHODS OF PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE AGENT

The present invention relates to novel compounds exhibiting good inhibitory activity versus Dipeptidyl Peptidase-IV(DPP-IV), methods of preparing the same and pharmaceutical compositions containing the same as an active agent.

ANTITHROMBOTIC ETHERS

This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor (I).